So instead, Rezvani decided to add the CAR gene to natural killer (NK) cells. “These cells are part of the innate immune system, and they’re very good at recognizing and killing cancer cells ...

Severe infection with Covid-19 has been found to produce a powerful cancer-fighting cell that can shrink tumors.

Clinical relevance: Receptor engineering has significantly advanced NK cell-based cancer immunotherapies. As technical hurdles are overcome, these innovative treatments are poised to revolutionize ...

Gilead Sciences' cell therapy Kite Pharma has bulked up its position in natural killer (NK) cell therapies, pledging up to $2.3 billion for a partnership with Shoreline Bioscience focusing on off ...

The first clinical program to go over involves the use of ImmunityBio's CAR-NK cell therapy CD19 t-haNK, which is being tested in the ongoing phase 1 QUILT 106 study. As I alluded to above ...

Conventional natural killer (cNK) cells, known for their crucial role in tumor immunity, face hurdles in penetrating tumor ...

CAR-T Cells: As the largest class in adoptive cell therapy, CAR-T cells are being engineered for greater precision, reduced toxicity, and durable anti-tumor responses. Advancements aim to address ...